SIMILASAN Rhume glob 15 g

7680508920357 CH-50892 20.01.1.
SIMILASAN Rhume glob 15 g
Fiches Amavita / Sun Store / Coop Vitality

Details

Product number
5089201
CPT
-
Packaging group
15
Unit
g
Composition
luffa operculata (HAB) D6 8.5 mg, luffa operculata (HAB) D12 1.0 mg, luffa operculata (HAB) D15 0.5 mg, calcii carbonas, xylitolum 600 mg, ad globulos pro 1 g corresp. 70-90 granula homoeopathica imbuta.

Articles (1)

Similasan Schnupfen, Globuli
Globuli
15
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
15/11/2023
Patient information leaflet
Français
15/11/2023
Patient information leaflet
Italien
15/11/2023

Detailed composition

Substance Quantity Type Category
luffa operculata (HAB)
8.5 MG Substance Wirkstoff (Principe actif)
luffa operculata (HAB)
1.0 MG Substance Wirkstoff (Principe actif)
luffa operculata (HAB)
0.5 MG Substance Wirkstoff (Principe actif)
calcii carbonas
- Substance HNIDK
xylitolum
600.0 MG Substance HNIDK

Authorization holder

Similasan AG

8916 Jonen

Authorization information

Swissmedic authorization number
50892
Drug name
Similasan Schnupfen, Globuli
Galenic form
GLO
Authorization status
Z
Dispensation category
D
First authorization
17/10/1991
Authorization expiration date
31/12/9999
IT number
20.01.1.
Domain
Human medicine
Field of application
Gemäss homöopathischem Arzneimittelbild bei Trockenem oder fliessendem Schnupfen, oft mit Druck in der Stirne oder in den Kieferhöhlen; Schnupfen mit Krustenbildung in der Nase; Heuschnupfen mit Stirnkopfschmerz; Trockenen Reizzuständen der Nase

Packaging details

Description (FR)
SIMILASAN Rhume glob 15 g
Description (DE)
SIMILASAN Schnupfen Glob 15 g
Market launch
17/10/1991
Narcotic (BTM)
No

Other packaging sizes

Buy us a coffee Explore the data